3.65 USD
+0.01 (+0.27%)
3.66 USD
+0.01 (+0.27%)
ChartMill assigns a Buy % Consensus number of 71% to RVNC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.25. This target is 43.76% above the current price.
RVNC was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about RVNC.
In the previous month the buy percentage consensus was at a similar level.
RVNC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-17 | Needham | Reiterate | Hold -> Hold |
| 2024-12-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-10-28 | Needham | Reiterate | Hold |
| 2024-09-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-08-13 | Needham | Downgrade | Buy -> Hold |
| 2024-08-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-08-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-08-09 | Needham | Reiterate | Buy -> Buy |
| 2024-08-09 | Stifel | Maintains | Buy -> Buy |
| 2024-08-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-05-10 | Needham | Maintains | Buy -> Buy |
| 2024-05-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-01 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Needham | Maintains | Buy -> Buy |
| 2024-02-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-29 | Mizuho | Downgrade | Buy -> Neutral |
| 2024-01-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-09 | Needham | Maintains | Buy -> Buy |
| 2024-01-09 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-11-22 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-09 | Needham | Maintains | Buy -> Buy |
| 2023-11-09 | Piper Sandler | Maintains | Overweight -> Overweight |
REVANCE THERAPEUTICS INC / RVNC FAQ
Can you provide the average price target for REVANCE THERAPEUTICS INC stock?
15 analysts have analysed RVNC and the average price target is 5.25 USD. This implies a price increase of 43.76% is expected in the next year compared to the current price of 3.65.
What is the consensus rating for RVNC stock?
The consensus rating for REVANCE THERAPEUTICS INC (RVNC) is 70.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for RVNC stock?
The number of analysts covering REVANCE THERAPEUTICS INC (RVNC) is 15.